- Home
- FMY vs ALUR Comparison
FMY vs ALUR Comparison
Compare FMY & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- ALUR
- Stock Information
- Founded
- FMY 2005
- ALUR 2009
- Country
- FMY United States
- ALUR United States
- Employees
- FMY N/A
- ALUR N/A
- Industry
- FMY Finance/Investors Services
- ALUR
- Sector
- FMY Finance
- ALUR
- Exchange
- FMY Nasdaq
- ALUR Nasdaq
- Market Cap
- FMY 52.1M
- ALUR 44.4M
- IPO Year
- FMY N/A
- ALUR N/A
- Fundamental
- Price
- FMY $12.02
- ALUR $0.39
- Analyst Decision
- FMY
- ALUR Strong Buy
- Analyst Count
- FMY 0
- ALUR 4
- Target Price
- FMY N/A
- ALUR $2.88
- AVG Volume (30 Days)
- FMY 10.1K
- ALUR 188.2K
- Earning Date
- FMY 01-01-0001
- ALUR 11-13-2024
- Dividend Yield
- FMY 6.98%
- ALUR N/A
- EPS Growth
- FMY N/A
- ALUR N/A
- EPS
- FMY N/A
- ALUR N/A
- Revenue
- FMY N/A
- ALUR $34,754,000.00
- Revenue This Year
- FMY N/A
- ALUR N/A
- Revenue Next Year
- FMY N/A
- ALUR $29.62
- P/E Ratio
- FMY N/A
- ALUR N/A
- Revenue Growth
- FMY N/A
- ALUR N/A
- 52 Week Low
- FMY $10.71
- ALUR $0.38
- 52 Week High
- FMY $12.17
- ALUR $4.54
- Technical
- Relative Strength Index (RSI)
- FMY 41.91
- ALUR 34.48
- Support Level
- FMY $11.93
- ALUR $0.49
- Resistance Level
- FMY $12.08
- ALUR $0.77
- Average True Range (ATR)
- FMY 0.12
- ALUR 0.07
- MACD
- FMY 0.01
- ALUR -0.02
- Stochastic Oscillator
- FMY 30.00
- ALUR 20.30
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.